Personalized Medicine for the Infertile Male.
Genomics
Male infertility
Personalized medicine
Proteomics
Journal
The Urologic clinics of North America
ISSN: 1558-318X
Titre abrégé: Urol Clin North Am
Pays: United States
ID NLM: 0423221
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
entrez:
3
10
2020
pubmed:
4
10
2020
medline:
21
10
2020
Statut:
ppublish
Résumé
Personalized medicine uses a patient's genotype, environment, and lifestyle choices to create a tailored diagnosis and therapy plan, with the goal of minimizing side effects, avoiding lost time with ineffective treatments, and guiding preventative strategies. Although most precision medicine strategies are still within the laboratory phase of development, this article reviews the promising technologies with the greatest potential to improve the diagnosis and treatment options for male infertility, including sperm cell transplantation, genomic editing, and new biomarker assays, based on the latest proteomic and epigenomic studies.
Identifiants
pubmed: 33008501
pii: S0094-0143(20)30043-4
doi: 10.1016/j.ucl.2020.07.003
pii:
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
523-536Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.